Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
Wall Street analysts lean neutral on Tesla, yet price targets keep climbing higher. Here is why the math behind the contradiction points in a direction most investors are not expecting.
Morgan Stanley just upgraded HPE to Overweight after a stock run that most investors missed entirely, and the valuation argument for buying near a 52-week high is more complicated than it looks.
CoreWeave's revenue has doubled for four straight quarters and its backlog dwarfs most competitors, yet the stock sits well below its peak. Whether the leverage and cash burn cancel out the growth story depends on one critical question our model tries to answer.
Analysts at Needham, Raymond James, Rosenblatt, Northland and B. Riley all raised their price targets on Coherent, with Rosenblatt setting the highest target at $500.
Cisco beat earnings, crushed revenue estimates, and racked up billions in AI orders, yet the stock cratered 7% anyway. Five analyst firms still raised their price targets, but the spread between the most bearish and most bullish tells a story of deep Wall Street disagreement about where Cisco goes from here.
Coherent (NYSE: COHR) reported fourth quarter results that exceeded expectations, supported by strong AI infrastructure demand in its data center optical networking business. The company issued an upbeat outlook for the first quarter, citing continued AI driven demand for its networking solutions. Nvidia committed a US$2b investment to expand Coherent's research, manufacturing, and operations capabilities as part of a wider partnership. This combination of stronger AI infrastructure demand...
Intel just posted its strongest revenue growth in over 15 years, yet shares sit more than 30% below their recent peak after a massive stock offering rattled investors. Whether that gap is a buying opportunity or a warning sign depends entirely on one unresolved question about its foundry business.
Investing.com -- Wolfe Research upgraded two major pharmaceutical companies to Outperform on Thursday, citing stronger growth prospects, attractive valuations and a series of upcoming clinical catalysts.
Investing.com -- Jefferies upgraded Five Below to Buy from Hold and raised its price target to $350 from $210, arguing that investors are underestimating structural improvements at the discount retailer and focusing too heavily on the temporary boost from its popular “squishy” products.
Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday.
Cisco Systems, Inc. (NASDAQ:CSCO) stock traded lower Thursday morning despite the company reporting better-than-expected fiscal fourth-quarter 2026 results and issuing guidance above Wall Street estimates. Revenue rose to $17.25 billion, topping the $16.82 billion analyst estimate. Adjusted earnings of $1.22 per share beat the $1.17 consensus estimate. Management described the current environment as the early stages of a multi-year networking and AI infrastructure supercycle. The company cited a
Cerebras Systems stock has climbed 28.1% over the past month, while a Discounted Cash Flow (DCF) intrinsic value estimate points to about 15.0% upside from the current market price, yet the company still scores poorly on broader valuation checks. That mix of strong recent gains, a supportive intrinsic value estimate and a low overall value score puts the current share price under closer scrutiny for investors thinking about the next move. Cerebras Systems is up 28.1% over the past month,...
Citi says Wix stock will rally in the second half of 2026. Here’s why the firm raised its price target on WIX shares today.
Investing.com -- Hilton Worldwide shares have come under pressure over the past month, but Deutsche Bank said investor expectations have now largely reset, creating a more attractive entry point as hotel demand remains resilient and the company's valuation has become more reasonable.
DexCom raises its 2026 revenue and margin outlook as G7 15 Day efficiencies lift profitability, while FX and transition costs remain key tests.
Rocket Lab just posted a record quarter and a backlog that shocked Wall Street, but the CEO is selling shares while betting billions on a deal that could either transform the company or crush it. Here is what our model says the stock is actually worth.
The downgrade questions whether Apple has enough product and AI momentum to support its premium expectations.
Hewlett Packard Enterprise (HPE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
CoreWeave (CRWV) shares rose sharply Wednesday after the company posted a second-quarter revenue bea
APP stock dropped almost 6% after a downgrade raised doubts about its 30% growth goal. Here's what the company said on its earnings call.
Investing.com -- Cybersecurity firm Okta is well positioned to benefit from growing enterprise demand for identity controls as companies deploy artificial intelligence agents, Citizens JMP Securities said on Wednesday, upgrading the stock and raising its price target.
These stocks have terrific track records for dividend growth, and they're likely to continue raising their payouts for the foreseeable future.
Investing.com -- CoreWeave shares jumped more than 15% on Tradegate Tuesday after the cloud-computing company posted its fifth consecutive quarter of record revenue and beat Wall Street estimates, underscoring continued strength in demand for AI computing.
High-yield ETFs built purely on yield rankings carry a hidden flaw that only shows up when it's too late, and one fund uses a decade-long dividend track record as a filter before yield ever enters the picture.
Argus Research upgraded Boeing stock to "Buy." Here’s why analyst Kristine Ruggeri believes BA shares will rip higher in the back half of 2026.
Jabil Inc (NYSE:JBL) shares gained about 5% on Tuesday afternoon after UBS upgraded the stock to 'Buy' and raised its estimates, citing a multiyear growth cycle driven by artificial intelligence investment, healthcare demand and expanding automation and robotics markets. UBS set a $430 price...
Jefferies cites supply-chain checks that suggest the company may have dropped plans for a high-end all-glass iPhone and lowered expected average selling price growth.
Baird upgrades First Solar stock to Outperform. Here’s why analyst Ben Kallo recommends owning FSLR shares in the second half of 2026.
Alphabet shares may have seen a short-term dip, but the long-term outlook remains bright.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
